Animal Genetics Market Size, Share and Growth Outlook, 2026

Animal Genetics Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Animal Genetics Market size is forecast to increase from $7.23 Billion in 2026 to $11.88 Billion in 2034 at a CAGR of 6.4% between 2026 and 2034.

The Animal Genetics market report provides detailed analysis and outlook of Animal Genetics segments including By Animal Type (Bovine, Porcine, Poultry, Canine & Feline, Ovine & Caprine, Equine ), By Solution (Animal Genetic Products, Genetic & Genomic Testing Services), By Service Type (DNA Typing / Genotyping, Genetic Disease Testing, Genetic Trait Testing, Parentage / Ancestry Testing), By Testing Technology (Polymerase Chain Reaction, Next-Generation Sequencing, Microarray Technology, Short Tandem Repeat ), By End-User (Commercial Livestock & Poultry Farms, Animal Breeding Organizations, Veterinary Hospitals & Diagnostic Clinics, Academic & Research Institutes) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Animal Genetics Industry Overview

Precision Livestock Genomics Advancing Genetic Improvement Programs

The animal genetics industry is undergoing significant transformation as genomic technologies, predictive analytics, and precision livestock management become increasingly integrated into breeding programs worldwide. Industry participants are focusing on improving animal productivity, disease resistance, sustainability, and environmental performance through advanced genetic selection tools. A major development in the sector is Zoetis’ expansion of its livestock precision agriculture strategy through the planned acquisition of the animal genomics business of Neogen Corporation. The transaction is intended to strengthen Zoetis’ capabilities in predictive livestock genetics, genomic testing, and data-driven breeding decisions. By integrating Neogen’s global genomics expertise into its precision animal health portfolio, Zoetis aims to expand predictive insights and diagnostic services that support more efficient livestock production systems.

Sustainability and Climate Resilience Driving Genetic Innovation

Genetic improvement programs are increasingly incorporating sustainability-related traits into breeding objectives. Zoetis has enhanced its CLARIFIDE Plus and Dairy Wellness Profit Index platforms by adding new genetic traits focused on environmental stewardship and heat resilience in dairy cattle. These additions reflect the growing importance of climate adaptation, resource efficiency, and sustainable livestock production within modern breeding programs. Livestock producers are seeking genomic solutions that support improved productivity while addressing environmental challenges, including heat stress and changing climatic conditions. The integration of sustainability-focused traits into genetic evaluation systems is helping producers make more informed breeding decisions while supporting long-term herd performance and resilience.

Breed Conservation and Indigenous Genetic Resource Protection Expanding

Government agencies and research institutions continue to strengthen efforts to preserve valuable livestock genetic diversity. The Indian Council of Agricultural Research – National Bureau of Animal Genetic Resources officially registered 16 new indigenous livestock and poultry breeds as part of its ongoing mission to document, conserve, and promote native animal genetic resources. These initiatives support biodiversity preservation, sustainable agricultural development, and livelihood security for small-scale farming communities. Breed registration programs are also contributing to structured conservation strategies and enhanced recognition of locally adapted genetic resources that possess unique productivity and resilience characteristics.

Government-Led Genetic Upgradation Programs Supporting Productivity

Public-sector initiatives remain a major driver of animal genetics development, particularly in emerging agricultural economies. Through the Rashtriya Gokul Mission, the Department of Animal Husbandry and Dairying continues to prioritize genetic upgradation of bovine populations through advanced breeding technologies and standardized reproductive management practices. Updated Standard Operating Procedures for artificial insemination technicians and the continued promotion of sex-sorted semen technology are supporting efforts to improve the productivity of indigenous cattle breeds. These programs aim to enhance genetic merit, reproductive efficiency, and livestock performance while supporting sustainable dairy sector development. The combination of genomic innovation, conservation initiatives, and government-supported breeding programs continues to shape the evolution of the global animal genetics industry.

Animal Genetics Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Animal Genetics market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Genus plc, Hendrix Genetics BV, Zoetis Inc., Topigs Norsvin, Cobb-Vantress, Inc. (Tyson Foods), Aviagen Group, CRV Holding B.V., Neogen Corporation, Groupe Grimaud, EW Group (Aviagen/Hy-Line). The Animal Genetics market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Animal Genetics industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Animal Genetics Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Animal Genetics companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Animal Genetics markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Animal Genetics Market Competitive Benchmarking and Company Analysis

Leading companies in Animal Genetics industry include- Genus plc, Hendrix Genetics BV, Zoetis Inc., Topigs Norsvin, Cobb-Vantress, Inc. (Tyson Foods), Aviagen Group, CRV Holding B.V., Neogen Corporation, Groupe Grimaud, EW Group (Aviagen/Hy-Line). The Animal Genetics market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Animal Genetics Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Animal Genetics market remains one of the strongest-performing segments in the country.
The US Animal Genetics Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Animal Genetics market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Animal Genetics industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Animal Genetics markets

Canada's strong Animal Genetics sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Animal Genetics market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Animal Genetics Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Animal Genetics market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Animal Genetics population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Animal Genetics industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Animal Genetics market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Animal Genetics sales through 2034

France Animal Genetics companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Animal Genetics Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Animal Genetics distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Animal Genetics Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Animal Genetics market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Animal Genetics industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Animal Genetics industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Animal Genetics Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Animal Genetics market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Animal Genetics market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Animal Genetics Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Animal Genetics Market Segmentation

By Animal Type
Bovine
Porcine
Poultry
Canine & Feline
Ovine & Caprine
Equine
By Solution
Animal Genetic Products
Genetic & Genomic Testing Services
By Service Type
DNA Typing / Genotyping
Genetic Disease Testing
Genetic Trait Testing
Parentage / Ancestry Testing
By Testing Technology
Polymerase Chain Reaction
Next-Generation Sequencing
Microarray Technology
Short Tandem Repeat
By End-User
Commercial Livestock & Poultry Farms
Animal Breeding Organizations
Veterinary Hospitals & Diagnostic Clinics
Academic & Research Institutes

Top Companies in Animal Genetics Industry

Genus plc
Hendrix Genetics BV
Zoetis Inc.
Topigs Norsvin
Cobb-Vantress, Inc. (Tyson Foods)
Aviagen Group
CRV Holding B.V.
Neogen Corporation
Groupe Grimaud
EW Group (Aviagen/Hy-Line)

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Biotech and Fermented Ingredient Integration to gain rapid penetration

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025